A study of cardiovascular involvement in cases of rheumatoid arthritis with high disease activity
Bathari, L.; Kotokey, R.K.; Chaliha, M.S.
Journal of the Association of Physicians of India 64(1): 151-152
2016
ISSN/ISBN: 0004-5772 PMID: 27728695 Document Number: 686835
Document emailed within 1 workday
Related Documents
Dryll, A.; Cazalis, P.; Debeyre, N.; de Sèze, S. 1975: Psoriatic rheumatism. Prospective study of 50 cases, without sacroiliac involvement and without rheumatoid factor, compared with 50 cases of rheumatoid arthritis La Nouvelle Presse Medicale 4(19): 1408-1412Abu Al Fadl, E.M.; Fattouh, M.; Allam, A.A. 2013: High IL-23 level is a marker of disease activity in rheumatoid arthritis Egyptian Journal of Immunology 20(2): 85-92
Chen, J.R.; Takahashi, M.; Suzuki, M.; Kushida, K.; Miyamoto, S.; Inoue, T. 1998: Pentosidine in synovial fluid in osteoarthritis and rheumatoid arthritis: relationship with disease activity in rheumatoid arthritis Journal of Rheumatology 25(12): 2440-2444
Halla, J.T.; Volanakis, J.E.; Hardin, J.G.; Schrohenloher, R.E. 1978: Immune complex detection and complement activity in rheumatoid arthritis: a comparative study of a radioimmunoassay using monoclonal rheumatoid factor, gel diffusion techniques and C4 activity Clinical and Experimental Immunology 34(2): 226-234
García-Bermúdez, M.; González-Juanatey, C.; Rodríguez-Rodríguez, L.; Vazquez-Rodriguez, T.R.; Miranda-Filloy, J.A.; Fernández-Gutierrez, B.; Llorca, J.; Martin, J.; González-Gay, M.A. 2011: Lack of association between LEP rs2167270 (19 G>A) polymorphism and disease susceptibility and cardiovascular disease in patients with rheumatoid arthritis Clinical and Experimental Rheumatology 29(2): 293-298
Rooney, M.; Whelan, A.; Feighery, C.; Bresnihan, B. 1989: The immunohistologic features of synovitis, disease activity and in vitro IgM rheumatoid factor synthesis by blood mononuclear cells in rheumatoid arthritis Journal of Rheumatology 16(4): 459-467
Rana, A.; Gogna, A.; Kabi, B.C. 2020: A study to correlate the serum levels of interleukin 6 with the disease activity indices (CDAi and DAS28 ESR) in seropositive rheumatoid arthritis patients Journal of the Association of Physicians of India 68(1): 69
Gonzalez-Gay, M.A.; Llorca, J.; Garcia-Unzueta, M.T.; Gonzalez-Juanatey, C.; De Matias, J.M.; Martin, J.; Redelinghuys, M.; Woodiwiss, A.J.; Norton, G.R.; Dessein, P.H. 2008: High-grade inflammation, circulating adiponectin concentrations and cardiovascular risk factors in severe rheumatoid arthritis Clinical and Experimental Rheumatology 26(4): 596-603
Dessein, P.H.; Lopez-Mejias, R.; Ubilla, B.; Genre, F.; Corrales, A.; Hernandez, J.L.; Ferraz-Amaro, I.; Tsang, L.; Pina, T.; Llorca, J.; Blanco, R.; Gonzalez-Juanatey, C.; Gonzalez-Gay, M.A. 2015: TNF-related apoptosis-inducing ligand and cardiovascular disease in rheumatoid arthritis Clinical and Experimental Rheumatology 33(4): 491-497
Scherler, M. 1978: Poncet--rheumatoid arthritis. Four cases of rheumatoid arthritis treated with tuberculostatics (author's transl1 Therapeutische Umschau. Revue Therapeutique 35(3): 201-206
Salaffi, F.; Migliore, A.; Scarpellini, M.; Corsaro, S.M.; Laganà, B.; Mozzani, F.; Varcasia, G.; Pusceddu, M.; Pomponio, G.; Romeo, N.; Maier, A.; Foti, R.; Scarpa, R.; Gasparini, S.; Bombardieri, S. 2010: Psychometric properties of an index of three patient reported outcome (PRO) measures, termed the CLinical ARthritis Activity (PRO-CLARA) in patients with rheumatoid arthritis. The NEW INDICES study Clinical and experimental rheumatology 28(2): 186-200
Grindulis, K.A.; Calverley, M.; Cox, C. 1984: Rheumatoid arthritis: is serum vitamin B12 high in active disease? Journal of Rheumatology 11(2): 211-212
Fantini, F.; Corradi, A.; Gerloni, V.; Failoni, S.; Gattinara, M.; Aprile, L.; Ferraris, W.; Arnoldi, C. 1997: The natural history of hip involvement in juvenile rheumatoid arthritis: a radiological and magnetic resonance imaging follow-up study Revue du Rhumatisme 64(10 Suppl): 173s-178s
Uemura, Y.; Hayashi, H.; Takahashi, T.; Saitho, T.; Umeda, R.; Ichise, Y.; Sendo, S.; Tsuji, G.; Kumagai, S. 2015: MMP-3 as a Biomarker of Disease Activity of Rheumatoid Arthritis Rinsho Byori. Japanese Journal of Clinical Pathology 63(12): 1357-1364
Mäkinen, H.; Kautiainen, H.; Hannonen, P.; Sokka, T. 2008: A new disease activity index for rheumatoid arthritis: Mean Overall Index for Rheumatoid Arthritis (MOI-RA) Journal of Rheumatology 35(8): 1522-1527
García-Bermúdez, M.; González-Juanatey, C.; Rodríguez-Rodríguez, L.; Miranda-Filloy, J.A.; Perez-Esteban, S.; Vazquez-Rodriguez, T.R.; Castañeda, S.; Balsa, A.; Fernández-Gutierrez, B.; Llorca, J.; González-Alvaro, I.; Martín, J.; González-Gay, M.A. 2011: Lack of association of NAMPT rs9770242 and rs59744560 polymorphisms with disease susceptibility and cardiovascular risk in patients with rheumatoid arthritis Clinical and Experimental Rheumatology 29(4): 681-688
Hanly, J.G.; Mosher, D.; Sutton, E.; Weerasinghe, S.; Theriault, D. 1996: Self-assessment of disease activity by patients with rheumatoid arthritis Journal of Rheumatology 23(9): 1531-1538
Swaak, A. 2006: Anemia of chronic disease in patients with rheumatoid arthritis: aspects of prevalence, outcome, diagnosis, and the effect of treatment on disease activity Journal of Rheumatology 33(8): 1467-1468
Kondo, H. 1997: Disease activity measures for rheumatoid arthritis clinical trials Ryumachi 37(6): 825-831
Scott, D.L. 1993: A simple index to assess disease activity in rheumatoid arthritis Journal of Rheumatology 20(3): 582-584